Molbio Diagnostics Invests $30 Million in OptraSCAN to Revolutionize Digital Pathology

BioNTech Acquires Chinese Oncology Firm Biotheus for $950M

The Care and Protection of Children Trust

CPCT Launches Groundbreaking Initiative to Provide Lifelong Free Treatment for Children with Spinal Muscular Atrophy (SMA) in Karnataka

Early Comprehensive Genomic Profiling Improves Cancer Treatment Outcomes, Study Shows

EMA Reverses Decision, Recommends Limited Approval for Eisai and Biogen’s Alzheimer’s Drug Leqembi

Exact Sciences Unveils Advances in Multi-Cancer Early Detection with Cancerguard™ Test

MSD and LaNova Medicines Enter Exclusive Global License Agreement for Novel Cancer Therapy, LM-299

Promising CAR T Cell Therapies from BMS and Cabaletta Bio Show Potential for Durable Remission in Severe Lupus

FDA Grants Accelerated Approval to PTC Therapeutics' KEBILIDI™, the First Gene Therapy for AADC Deficiency in the U.S.

Association for Molecular Pathology Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Hospitals and Public Health Laboratories

Philips India Unveils Advanced Azurion Imaging System to Revolutionize Cardiac and Neurovascular Care

Tempus AI Study Highlights Benefits of Dual RNA and DNA Sequencing for Advanced Lung Cancer

Ontada and Datavant Partner to Expand Access to Real-World Oncology Data for Accelerated Cancer Innovation

Tempus AI and Flatiron Health Partner to Integrate Genomic Testing into OncoEMR for Enhanced Oncology Care

Flare Therapeutics and Roche Forge Strategic Partnership to Discover Precision Oncology Therapies Targeting Transcription Factors

Home
/
update
/
details

Neuberg Diagnostics Unveils Geniee: A Personalized Genomics Platform

NextEdge Admin

19 Sep 2024

2 min 31 sec

Chennai-based Neuberg Diagnostics, a global pioneer in advanced healthcare diagnostics, has introduced its revolutionary personalized genomics platform, “Geniee – Decode Your DNA.” This launch marks a major advancement in personalized healthcare, positioning Neuberg at the cutting edge of genetic testing and customized medicine.

Geniee is designed to provide deeply personalized health insights, equipping users with the critical knowledge to make informed choices about their health and well-being based on their individual genetic profiles.

More than just a risk assessment tool, Neuberg's Geniee represents a wellness transformation. This mobile platform offers insights into how an individual’s genes affect their response to medications, dietary needs, fitness routines, and nutritional requirements. By delivering comprehensive genetic insights, Geniee allows users to take proactive control of their health. With these insights, individuals can optimize their diets, identify nutrient deficiencies, enhance fitness plans, and take preventive measures for a healthier life.

Central to this innovation is the launch of the Complete Wellness Genetics Test alongside the Geniee app. This advanced genetic test provides in-depth analysis of a person’s DNA, offering clear guidance on lifestyle adjustments to promote longevity and well-being. Whether it's determining a predisposition to obesity, identifying vitamin A or other nutritional deficiencies, or offering diet recommendations, Geniee empowers users to personalize their health strategies. Additionally, users benefit from ongoing updates to the app, which reflect both their unique genetic makeup and the latest advancements in genomics.

Through its comprehensive genetic testing, Geniee also helps individuals and healthcare professionals understand how the body metabolizes and responds to medications.